Larvol Delta - Considerations-for-the-discovery-and-development-of-3chymotrypsinlike-cysteine-protease-inhibitors-targeting-SARSCoV2-infection

GC376 - Anivive

PF-07321332 - Pfizer

CDI-45205 - Cocrystal Pharma

PF-07304814 - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/34029993

May 25, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next